Epigenetic alterations and their clinical implications in esophageal squamous cell carcinoma

Gen Thorac Cardiovasc Surg. 2013 May;61(5):262-9. doi: 10.1007/s11748-013-0235-3. Epub 2013 Mar 26.

Abstract

Alterations in the regulation of gene expression that do not involve a change in the DNA sequence have been increasingly recognized as an important key event of carcinogenesis, referred to as "epigenetic" changes. Major epigenetic mechanisms include the methylation of cytosines in DNA, changes of histone and chromatin structure by covalent posttranslational modifications of histone proteins and alterations in the expression of microRNAs. These epigenetic alterations have also been identified in esophageal squamous cell carcinoma (ESCC). In this brief review, we will discuss DNA hypermethylation of the tumor suppressor gene promoters, histone modifications including histone acetylation/deacetylation and histone methylation and microRNAs in ESCC. Clinical implications of these epigenetic alterations in ESCC will be also discussed.

Publication types

  • Review

MeSH terms

  • Acetylation
  • Biomarkers, Tumor / analysis
  • Carcinoma, Squamous Cell / genetics*
  • Carcinoma, Squamous Cell / metabolism
  • Carcinoma, Squamous Cell / therapy
  • DNA Methylation
  • Epigenesis, Genetic*
  • Esophageal Neoplasms / genetics*
  • Esophageal Neoplasms / metabolism
  • Esophageal Neoplasms / therapy
  • Esophageal Squamous Cell Carcinoma
  • Gene Expression
  • Histones / genetics
  • Histones / metabolism
  • Humans
  • MicroRNAs / metabolism
  • Protein Processing, Post-Translational

Substances

  • Biomarkers, Tumor
  • Histones
  • MicroRNAs